Tag: New Treatment for Merkel Cell Carcinoma

Home / New Treatment for Merkel Cell Carcinoma

Categories

Retifanlimab-dlwr is approved by FDA for metastatic or recurrent locally advanced Merkel cell carcinoma

April 2023: Retifanlimab-dlwr (Zynyz, Incyte Corporation) received fast approval from the Food and Drug Administration to treat adult patients with metastatic or recurrent locally advanced Merkel cel...
new-treatment-for-merkel-cell-carcinoma

Scan the code